Fig. 5From: Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s diseasea Propose binding of C1 at the active gorge site. b Propose binding of C1 at the peripheral anionic site [7]Back to article page